Predictive Immunohistochemical Markers Related to Drug Selection for Patients Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Xin,Ma ^[1] ; Lei,Wang ^[1] ; Hongzhao,Li ^[1] ; Yu,Zhang ^[1] ; Yu,Gao ^[1] ; Gang,Guo ^[1] ; Kan,Liu ^[1] ; Qingyu,Meng ^[1] ; Chaofei,Zhao ^[1] ; Dianjun,Wang ^[2] ; Zhigang,Song ^[2] ; Xu,Zhang ^[1]

作者单位： Department of Urology, State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital/Chinese PLA Medical Academy, Beijing, P. R. China. ^[1] Department of Pathology, Chinese PLA General Hospital/Chinese PLA Medical Academy, Beijing, P. R. China. ^[2]

主题词成年人(Adult);抗肿瘤药(Antineoplastic Agents);碱性螺旋-环-螺旋转录因子类(Basic Helix-Loop-Helix Transcription Factors);癌, 肾细胞(Carcinoma, Renal Cell);女(雌)性(Female);人类(Humans);吲哚类(Indoles);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);肾切除术(Nephrectomy);烟酰胺(Niacinamide);苯脲化合物(Phenylurea Compounds);预后(Prognosis);前瞻性研究(Prospective Studies);吡咯类(Pyrroles);受体, 血小板源生长因子β(Receptor, Platelet-Derived Growth Factor beta);组织阵列分析(Tissue Array Analysis);血管内皮生长因子受体1(Vascular Endothelial Growth Factor Receptor-1)

DOI 10.1038/srep30886

PMID 27488093

发布时间 2018-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览18

Scientific reports

2016年6卷

30886页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Predictive Immunohistochemical Markers Related to Drug Selection for Patients Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer.

Scientific reports

相似文献

Scientific reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Predictive Immunohistochemical Markers Related to Drug Selection for Patients Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer.

Scientific reports

相似文献

Scientific reports

相关期刊

检索历史清除